Last updated on October 2017

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome


Brief description of study

The study aim is to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.

Clinical Study Identifier: NCT02468193

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Fukuoka city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Fukushima-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kobe-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nishinomiya-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Yokohama, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sendai-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Chiba, Japan
  Connect »